StreetInsider.com News Articles

Axonex AI implements 2-for-5 reverse stock split on Nasdaq

Tue, 20 Oct 2026 11:44:06 -0400

Axonex AI Group Limited (NASDAQ: AXNX), a Hong Kong-based company focused on artificial intelligence, robotics, and interior design services, is implementing a 2-for-5 reverse stock split of all its issued and unissued shares, effective at the opening of trading on October 22, 2026.

The reverse stock split, approved by the company's board of directors on October 2, 2026, will reduce the number of outstanding Class A ordinary shares from 15,190,742 to approximately 6,076,297. Every five shares will be consolidated into two shares. Fractional shares resulting from the split will be rounded up to the next whole number rather than issued as

Axonex AI implements 2-for-5 reverse stock split on Nasdaq

Tue, 20 Oct 2026 11:44:06 -0400

Axonex AI Group Limited Announces 2-for-5 Reverse Stock Split

Tue, 20 Oct 2026 11:43:00 -0400

Hong Kong, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Axonex AI Group Limited (“Axonex” or the “Company”, NASDAQ: AXNX), a Hong Kong-based company with a strategic focus on artificial intelligence (AI) and robotics, and an established business interior design and fit-out works provider, announces that it is implementing a reverse stock split of all of the Company’s issued and unissued shares, including the Class A ordinary shares with no par value (the “Class A Ordinary Shares”) and Class B ordinary shares with no par value (the “Class B Ordinary Shares,” together with the Class A Ordinary Shares,

Axonex AI Group Limited Announces 2-for-5 Reverse Stock Split

Tue, 20 Oct 2026 11:43:00 -0400

Axonex AI Group Limited Announces 2-for-5 Reverse Stock Split

Tue, 20 Oct 2026 11:43:00 -0400

Axonex AI Group Limited Announces 2-for-5 Reverse Stock Split

Tue, 20 Oct 2026 11:43:00 -0400

Axonex AI unit joins Hong Kong embodied AI hub, launches TOMO robot

Thu, 15 Oct 2026 08:31:14 -0400

Axonex AI Group Limited (NASDAQ: AXNX) announced that its indirect majority-owned joint venture, Rice Robotics (Hong Kong) Limited, has joined the Embodied AI International Applications Hub as one of its first batch of technology partners, according to a company press release dated Oct. 15, 2026.

The Hub was launched by the Hong Kong Industrial Artificial Intelligence and Robotics Centre (FLAIR), under the Hong Kong Productivity Council. The platform is described as Hong Kong's first dedicated to the training, validation and real-world deployment of embodied AI and humanoid robotics technologies.

Under an agreement with FLAIR, Rice Robotics HK will provide its robotic platform

Axonex AI Group Joins FLAIR’s Embodied AI International Applications Hub and Launches Education Humanoid TOMO

Thu, 15 Oct 2026 08:30:00 -0400

Collaboration to Explore Real-world Applications in Education and Manufacturing

Hong Kong, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Axonex AI Group Limited (“Axonex AI” or the “Company”, together with its subsidiaries, the “Group”), a Hong Kong-based company strategically focused on artificial intelligence (AI) and robotics as its primary growth engine, today announced two breakthroughs in its humanoid robots and embodied AI business. Its indirect majority-owned joint venture entity, Rice Robotics (Hong Kong) Limited (“Rice Robotics HK”), has joined the Embodied AI International Applications Hub (the

Axonex AI Group Joins FLAIR’s Embodied AI International Applications Hub and Launches Education Humanoid TOMO

Thu, 15 Oct 2026 08:30:00 -0400

Collaboration to Explore Real-world Applications in Education and Manufacturing

Mint Incorporation rebrands as Axonex AI Group, changes ticker

Fri, 09 Oct 2026 08:32:40 -0400

Mint Incorporation Limited has changed its name to Axonex AI Group Limited and will begin trading on the Nasdaq Capital Market under the ticker symbol AXNX on October 13, 2026, according to a press release. The name change took effect on September 28, 2026. The company previously traded under the ticker MIMI.

The Hong Kong-based company said the rebrand reflects its ongoing shift toward artificial intelligence and robotics. The company operates two subsidiaries in this space: Axonex AI Limited, a wholly-owned subsidiary, and Rice Robotics AGI Holding Limited, a majority-owned subsidiary.

The company has introduced several robot products, including the FLOKI Minibot

Mint Incorporation rebrands as Axonex AI Group, changes ticker

Fri, 09 Oct 2026 08:32:40 -0400

The company has introduced several robot products, including the FLOKI Minibot

Mint Incorporation rebrands as Axonex AI Group, changes ticker

Fri, 09 Oct 2026 08:32:40 -0400

The company has introduced several robot products, including the FLOKI Minibot

Mint Incorporation rebrands as Axonex AI Group, changes ticker

Fri, 09 Oct 2026 08:32:40 -0400

The company has introduced several robot products, including the FLOKI Minibot

Axonex AI Group Limited (NASDAQ: AXNX) Solidifies Transformation into an AI and Robotics-Focused Company

Fri, 09 Oct 2026 08:30:00 -0400

Formerly Mint Incorporation Limited (NASDAQ: MIMI),
the Company Unveils New Corporate Identity and Ticker
to Reflect Strategic Focus on AI and Robotics as Its Primary Growth Engine

Hong Kong, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mint Incorporation Limited today announced that it has changed the Company's name to Axonex AI Group Limited (“Axonex AI” or the “Company”, together with its subsidiaries, the “Group”), as part

Axonex AI Group Limited (NASDAQ: AXNX) Solidifies Transformation into an AI and Robotics-Focused Company

Fri, 09 Oct 2026 08:30:00 -0400

Formerly Mint Incorporation Limited (NASDAQ: MIMI),
the Company Unveils New Corporate Identity and Ticker
to Reflect Strategic Focus on AI and Robotics as Its Primary Growth Engine

Axonex AI Group Limited (NASDAQ: AXNX) Solidifies Transformation into an AI and Robotics-Focused Company

Fri, 09 Oct 2026 08:30:00 -0400

Formerly Mint Incorporation Limited (NASDAQ: MIMI),
the Company Unveils New Corporate Identity and Ticker
to Reflect Strategic Focus on AI and Robotics as Its Primary Growth Engine

Axonex AI Group Limited (NASDAQ: AXNX) Solidifies Transformation into an AI and Robotics-Focused Company

Fri, 09 Oct 2026 08:30:00 -0400

Formerly Mint Incorporation Limited (NASDAQ: MIMI),
the Company Unveils New Corporate Identity and Ticker
to Reflect Strategic Focus on AI and Robotics as Its Primary Growth Engine

Raymond W. Cohen named chairman of CAIRDAC board of directors

Thu, 24 Sep 2026 03:49:14 -0400

CAIRDAC, a French medical technology company developing a leadless, self-powered cardiac pacemaker, announced the appointment of Raymond W. Cohen as chairman of its board of directors.

Cohen has more than four decades of medical technology industry experience. He co-founded and served as chief executive of Axonics, Inc. (Nasdaq: AXNX), a maker of implantable neuromodulation devices that held its initial public offering in 2018 and was acquired by Boston Scientific in late 2024 for $3.7 billion. In 2025, Cohen, as chairman of SoniVie, Ltd., led the sale of that company for $600 million, and later that year led the sale of Nalu

Raymond W. Cohen named chairman of CAIRDAC board of directors

Thu, 24 Sep 2026 03:49:14 -0400

CAIRDAC, a French medical technology company developing a leadless, self-powered cardiac pacemaker, announced the appointment of Raymond W. Cohen as chairman of its board of directors.

CAIRDAC Announces the Appointment of Raymond W. Cohen as Chairman of its Board of Directors

Thu, 24 Sep 2026 03:49:00 -0400

ANTONY, France--(BUSINESS WIRE)-- CAIRDAC, SA, a pre-revenue stage medtech company developing a leadless, self-powered cardiac pacemaker (Autonomous Leadless Pacing System), today announced the appointment of Raymond W. Cohen as chairman of its board of directors.

“We are thrilled to welcome Mr. Cohen to the CAIRDAC board of directors,” said Edouard Fonck, Chief Executive Officer of CAIRDAC, “Ray’s extensive track record in leading, scaling and exiting medical technology companies will, no doubt, be invaluable as we advance this exciting project.”

Mr. Cohen, an accredited public company director and accomplished medical technology executive, has over four decades of medtech industry experience.

CAIRDAC Announces the Appointment of Raymond W. Cohen as Chairman of its Board of Directors

Thu, 24 Sep 2026 03:49:00 -0400

Mr. Cohen, an accredited public company director and accomplished medical technology executive, has over four decades of medtech industry experience.

CAIRDAC Announces the Appointment of Raymond W. Cohen as Chairman of its Board of Directors

Thu, 24 Sep 2026 03:49:00 -0400

Mr. Cohen, an accredited public company director and accomplished medical technology executive, has over four decades of medtech industry experience.

CAIRDAC Announces the Appointment of Raymond W. Cohen as Chairman of its Board of Directors

Thu, 24 Sep 2026 03:49:00 -0400

Mr. Cohen, an accredited public company director and accomplished medical technology executive, has over four decades of medtech industry experience.

Biobeat Technologies appoints Raymond Cohen as board chairman

Thu, 21 Aug 2025 07:00:29 -0400

Biobeat Technologies Ltd., a medical device company specializing in wearable blood pressure monitoring systems, announced the appointment of Raymond W. Cohen as Chairman of the Board of Directors.

The Israel-based company has developed an FDA-cleared patch device that monitors multiple physiological parameters including continuous cuff-less ambulatory blood pressure, oxygen saturation, respiration rate, pulse rate, heart rate variability, ECG, temperature and cardiac output. The device transmits patient data to a cloud-based system for analysis.

Cohen brings over four decades of life science industry experience to the role. He co-founded and served as CEO of Axonics, Inc. (NASDAQ: AXNX), a neuromodulation device company that

Biobeat Technologies appoints Raymond Cohen as board chairman

Thu, 21 Aug 2025 07:00:29 -0400

Biobeat Technologies Ltd., a medical device company specializing in wearable blood pressure monitoring systems, announced the appointment of Raymond W. Cohen as Chairman of the Board of Directors.

Cohen brings over four decades of life science industry experience to the role. He co-founded and served as CEO of Axonics, Inc. (NASDAQ: AXNX), a neuromodulation device company that